Literature DB >> 26691220

Diaphragmatic peritonectomy vs. full thickness resection with pleurectomy during Visceral-Peritoneal Debulking (VPD) in 100 consecutive patients with stage IIIC-IV ovarian cancer: A surgical-histological analysis.

Hooman Soleymani Majd1, Federico Ferrari1, Sanjiv Manek2, Kumar Gubbala1, Riccardo Garruto Campanile1, Kieran Hardern1, Roberto Tozzi3.   

Abstract

OBJECTIVE: To compare the surgical and histological outcomes of diaphragmatic peritonectomy vs. full thickness resection with pleurectomy during Visceral-Peritoneal Debulking.
METHODS: Service evaluation protocol (Trust number 3265). All patients with stage IIIC-IV ovarian cancer who had diaphragmatic surgery between April 2009 and November 2013 were included. Clinical notes and histology reports were reviewed. Additional histology sections were undertaken. Patients were divided in Groups 1 (peritonectomy) and 2 (pleurectomy). The outcomes of interest were: surgical (intra- and post-operative morbidity, pulmonary morbidity, mortality, rate of complete resection) and histological (rate of diaphragmatic peritoneum, muscle and pleural involvement, rate of microscopic diaphragmatic free margins).
RESULTS: Sixty four patients had diaphragmatic peritonectomy (Group 1), 36 patients full thickness diaphragmatic resection with pleurectomy (Group 2). There was no significant difference in the rate of mortality (3% in both groups), overall intra- and post-operative morbidity (32.8% vs. 38.8%), pulmonary morbidity (9.3% vs. 19%, P=0.14). Histology showed tumor invasion in the diaphragmatic peritoneum (96%), muscle (28%) and pleura (19.4%). Microscopic free margins were seen in 86% vs. 92% in Groups 1 and 2.
CONCLUSIONS: Our study demonstrated that, in patients with ovarian cancer, diaphragmatic involvement extends to the muscle in almost 30% and to the pleura in 20% of the patients. Overall and specific morbidity was not significantly different when comparing peritonectomy vs. pleurectomy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26691220     DOI: 10.1016/j.ygyno.2015.12.004

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  13 in total

Review 1.  Narrative review of liver mobilization, diaphragm peritonectomy, full-thickness diaphragm resection, and reconstruction.

Authors:  Wonkyo Shin; Jaehee Mun; Sang-Yoon Park; Myong Cheol Lim
Journal:  Gland Surg       Date:  2021-03

2.  Extraperitoneal Approach During Peritonectomy in the Right Upper Quadrant for Peritoneal Metastases from Ovarian Malignancies.

Authors:  Miklos Acs; Hubert Leebmann; Sebastian Häusler; Philipp Harter; Pompiliu Piso
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

3.  Application of J-Plasma in the excision of diaphragmatic lesions as part of complete cytoreduction in patients with advanced ovarian cancer.

Authors:  Vasilios Theodoulidis; Anastasia Prodromidou; Emmanouil Stamatakis; Nicholas Alexakis; Alexandros Rodolakis; Dimitrios Haidopoulos
Journal:  Mol Clin Oncol       Date:  2022-05-18

4.  Risk factors of perioperative complications and management with enhanced recovery after primary surgery in women with epithelial ovarian carcinoma in a single center.

Authors:  Min Li; Tianjiao Zhang; Jing Zhu; Yuebo Li; Wenying Chen; Yanhu Xie; Wei Zhang; Rongzhu Chen; Wei Wei; Guihong Wang; Jiwei Qin; Weidong Zhao; Dabao Wu; Zhen Shen; Björn Nashan; Ying Zhou
Journal:  Oncol Lett       Date:  2022-03-16       Impact factor: 3.111

5.  Association of Diaphragmatic Surgery as Part of Cytoreductive Effort in Advanced Stage Ovarian Cancer.

Authors:  Nicolae Bacalbasa; Irina Balescu; Cristian Balalau; Olivia Ionescu; Claudia Stoica
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

6.  Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma.

Authors:  Shuang Ye; Tiancong He; Shanhui Liang; Xiaojun Chen; Xiaohua Wu; Huijuan Yang; Libing Xiang
Journal:  BMC Cancer       Date:  2017-05-05       Impact factor: 4.430

7.  Peritoneal carcinomatosis index as a predictor of diaphragmatic involvement in stage III and IV ovarian cancer.

Authors:  Antoni Llueca; Anna Serra; José Luis Herraiz; Isabel Rivadulla; Luis Gomez-Quiles; Juan Gilabert-Estelles; Javier Escrig
Journal:  Onco Targets Ther       Date:  2018-05-15       Impact factor: 4.147

8.  Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC-IV ovarian cancer.

Authors:  Roberto Tozzi; Jvan Casarin; Ahmet Baysal; Gaetano Valenti; Yakup Kilic; Hooman Soleymani Majd; Matteo Morotti
Journal:  J Gynecol Oncol       Date:  2018-11-30       Impact factor: 4.401

9.  Tozzi classification of diaphragmatic surgery in patients with stage IIIC-IV ovarian cancer based on surgical findings and complexity.

Authors:  Roberto Tozzi; Federico Ferrari; Joost Nieuwstad; Riccardo Garruto Campanile; Hooman Soleymani Majd
Journal:  J Gynecol Oncol       Date:  2019-09-02       Impact factor: 4.401

10.  Feasibility of laparoscopic diaphragmatic peritonectomy during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer.

Authors:  Roberto Tozzi; Hooman Soleymani Majd; Riccardo Garruto Campanile; Federico Ferrari
Journal:  J Gynecol Oncol       Date:  2020-09       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.